Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC
Dr Pilar Garrido presents at ecancer's Milan Summit on Precision Medicine 2018 about the current situation regarding lung cancer and precision medicine.
She outlines some of the genomic targets for lung cancer, including immunotherapy biomarkers.
Dr Garrido also gives her thoughts on the challenges when using NGS.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine
Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC
Powering equity in cancer care through digital health
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Relapsed refractory multiple myeloma
Lung Cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania